Indeed, a significant reduction of tumor NKG2D and NCR-ligands together with a low expression of MHC class I molecules correlates not only with disease stages but also with a decrease of NK cell killing susceptibility [139,140]. This evidence concerns the gene KLRK1 and neoplasm.